Trademark Snap Shot Publication Stylesheet (Table presents the data on Publication Approval) |
|||
OVERVIEW |
|||
SERIAL NUMBER | 88071814 | FILING DATE | 08/09/2018 |
REG NUMBER | 0000000 | REG DATE | N/A |
REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
INTL REG # | N/A | INTL REG DATE | N/A |
TM ATTORNEY | NOVAKOVIC, MIROSLAV |
L.O. ASSIGNED | 108 |
PUB INFORMATION |
|||
RUN DATE | 04/30/2020 | ||
PUB DATE | N/A | ||
STATUS | 680-APPROVED FOR PUBLICATION | ||
STATUS DATE | 04/29/2020 | ||
LITERAL MARK ELEMENT | APTIVA | ||
DATE ABANDONED | N/A | DATE CANCELLED | N/A |
SECTION 2F | NO | SECTION 2F IN PART | NO |
SECTION 8 | NO | SECTION 8 IN PART | NO |
SECTION 15 | NO | REPUB 12C | N/A |
RENEWAL FILED | NO | RENEWAL DATE | N/A |
DATE AMEND REG | N/A |
FILING BASIS |
|||||
FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
44D | YES | 44D | YES | 44D | NO |
44E | NO | 44E | NO | 44E | NO |
66A | NO | 66A | NO | ||
NO BASIS | NO | NO BASIS | NO |
MARK DATA |
|
STANDARD CHARACTER MARK | YES |
LITERAL MARK ELEMENT | APTIVA |
MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
PARTY TYPE | 10-ORIGINAL APPLICANT |
NAME | Inova Diagnostics, Inc. |
ADDRESS | 9900 Old Grove Rd San Diego, CA 92131 |
ENTITY | 03-CORPORATION |
CITIZENSHIP | California |
GOODS AND SERVICES |
|
INTERNATIONAL CLASS | 001 |
DESCRIPTION TEXT | Chemical products for scientific purposes, namely, biomarkers for scientific testing; reagents for scientific and research use; all of the foregoing for use in connection with a fluorescence multi-analyte immunoassay system for medical research use and not for use in connection with detecting nucleic acid |
INTERNATIONAL CLASS | 005 |
DESCRIPTION TEXT | Pharmaceutical and veterinary products, namely, fluorescence multi-analyte immunoassay system for medical diagnostic use, namely, gastrointestinal, neurological, autoimmune, infectious, hepatological, rheumatologic, nephrological, dermatological, coagulation, endocrine, pulmonologic, immune system related, and respiratory diseases; clinical diagnostic assays for medical purposes, namely, identifying and diagnosing of gastrointestinal, neurological, autoimmune, infectious, hepatological, rheumatologic, nephrological, dermatological, coagulation, endocrine, pulmonologic, immune system related, and respiratory diseases; all of the foregoing for use in connection with a fluorescence multi-analyte immunoassay system for medical diagnostic use and not for use in connection with detecting nucleic acid |
INTERNATIONAL CLASS | 009 |
DESCRIPTION TEXT | Laboratory apparatus for testing of plasma, serum, sputum, fecal, and urine samples for research purposes; all of the foregoing for use in connection with a fluorescence multi-analyte immunoassay system for laboratory research use and not for use in connection with detecting nucleic acid |
INTERNATIONAL CLASS | 010 |
DESCRIPTION TEXT | Apparatus and instruments for medical diagnosis, namely, medical apparatus for diagnosing, monitoring, and treating gastrointestinal, neurological, autoimmune, infectious, hepatological, rheumatologic, nephrological, dermatological, coagulation, endocrine, pulmonologic, immune system related, and respiratory diseases; all of the foregoing for use in connection with a fluorescence multi-analyte immunoassay system for medical diagnostic use and not for use in connection with detecting nucleic acid |
GOODS AND SERVICES CLASSIFICATION |
|||||||
INTERNATIONAL CLASS | 001 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
INTERNATIONAL CLASS | 009 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
INTERNATIONAL CLASS | 010 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
CHANGE IN REGISTRATION | NO |
FOREIGN INFORMATION |
|
PRIORITY CLAIMED | SEC. 44(D) ON Tonga |
APPLICATION NO. | TOM1803534 |
APPLICATION FILING DATE | 02/28/2018 |
FOREIGN REG NO. | N/A |
FOREIGN REG DATE | N/A |
FOREIGN RNWL NUM | N/A |
DATE OF FOREIGN RNWL | N/A |
FOREIGN EXPIRATION | N/A |
FOREIGN RNWL EXPIRATION | N/A |
PROSECUTION HISTORY |
||||
DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
04/29/2020 | EXPT | T | EXPARTE APPEAL TERMINATED | 034 |
04/29/2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 033 |
04/28/2020 | ALIE | A | ASSIGNED TO LIE | 032 |
04/24/2020 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | 031 |
04/24/2020 | EXPI | T | EX PARTE APPEAL-INSTITUTED | 030 |
04/24/2020 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY | 029 |
04/24/2020 | EXAF | T | EXPARTE APPEAL RECEIVED AT TTAB | 028 |
04/14/2020 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | 027 |
04/14/2020 | GNFR | O | FINAL REFUSAL E-MAILED | 026 |
04/14/2020 | CNFR | R | FINAL REFUSAL WRITTEN | 025 |
03/11/2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 024 |
03/11/2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 023 |
03/11/2020 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 022 |
01/25/2020 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | 021 |
01/25/2020 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED | 020 |
01/25/2020 | CNSI | R | SUSPENSION INQUIRY WRITTEN | 019 |
07/02/2019 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 018 |
07/02/2019 | GNSL | S | LETTER OF SUSPENSION E-MAILED | 017 |
07/02/2019 | CNSL | R | SUSPENSION LETTER WRITTEN | 016 |
06/11/2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 015 |
06/11/2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 014 |
06/11/2019 | ALIE | A | ASSIGNED TO LIE | 013 |
06/06/2019 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 012 |
06/05/2019 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 011 |
06/05/2019 | GNSL | S | LETTER OF SUSPENSION E-MAILED | 010 |
06/05/2019 | CNSL | R | SUSPENSION LETTER WRITTEN | 009 |
05/16/2019 | AMPX | O | APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED | 008 |
05/16/2019 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | 007 |
12/06/2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 006 |
12/06/2018 | GNRT | F | NON-FINAL ACTION E-MAILED | 005 |
12/06/2018 | CNRT | R | NON-FINAL ACTION WRITTEN | 004 |
11/28/2018 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
08/16/2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
08/13/2018 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
ATTORNEY | Brian Focarino |
CORRESPONDENCE ADDRESS | Brian Focarino COOLEY LLP 1299 PENNSYLVANIA AVE NW STE 700 WASHINGTON, DC 20004-2400 |
DOMESTIC REPRESENTATIVE | NONE |